Injection of Stem Cells (ASCOT-1) - IVI Fertility

August 07,2024

This procedure consists of activating stem cells present in other parts of the body that with sufficient biological stimulation can become cells with ovarian functions. The injection of enriched plasma into these cells gives us the possibility of restoring the physiological processes involved in follicular recruitment.

Stem Cell Therapies for Human Infertility: Advantages and Challenges - Jin-Xiang Wu, Tian Xia, Li-Ping She, Shu Lin, Xiang-Min Luo, 2022

Intraovarian injection of mesenchymal stem cells improves oocyte yield and in vitro embryo production in a bovine model of fertility loss

Latest Studies IVIRMA ) Innovation

Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders - ScienceDirect

SRI Awards IVIRMA for its Studies on Ovarian Activation, Embryo Development and Implantation. - IVIRMA Innovation

Injection of Stem Cells (ASCOT-1) - IVI Fertility

Centre of Excellence Ovarian Rejuvenation - IVI Fertility

A comparative study of Mesenchymal Stem Cells transplantation approach to antagonize age-associated ovarian hypofunction with consideration of safety and efficiency - ScienceDirect

Infertility treatment with stem cells, female infertility

Injection of Stem Cells (ASCOT-1) - IVI Fertility

Antioxidants, Free Full-Text

Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP)

PDF) Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency